Skip to content
  • Mon. Jun 16th, 2025

Producers Online

Producers Online

  • Home
  • Producers online

Latest Post

Robex weiterhin im Plan für erste Goldproduktion bei Kiniero im vierten Quartal 2025 Robex reste en bonne voie pour une première coulée d’or à Kiniero au quatrième trimestre 2025 [Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT) Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor
Producers

Robex weiterhin im Plan für erste Goldproduktion bei Kiniero im vierten Quartal 2025

June 16, 2025 admin
Producers

Robex reste en bonne voie pour une première coulée d’or à Kiniero au quatrième trimestre 2025

June 16, 2025 admin
Producers

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients

June 16, 2025 admin
Producers

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

June 16, 2025 admin
Producers

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

June 16, 2025 admin
  • Latest
  • Popular
  • Trending
Robex weiterhin im Plan für erste Goldproduktion bei Kiniero im vierten Quartal 2025
Producers
Robex weiterhin im Plan für erste Goldproduktion bei Kiniero im vierten Quartal 2025
Robex reste en bonne voie pour une première coulée d’or à Kiniero au quatrième trimestre 2025
Producers
Robex reste en bonne voie pour une première coulée d’or à Kiniero au quatrième trimestre 2025
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
Producers
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Producers
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Brazil upholds 18% tariff on US ethanol imports
Producers
Brazil upholds 18% tariff on US ethanol imports
AACC rebrands itself
Producers
AACC rebrands itself
Vital role of food, agriculture explored in ABA study
Producers
Vital role of food, agriculture explored in ABA study
Wheat Quality Council highlights sustainability, regulation, nutrition
Producers
Wheat Quality Council highlights sustainability, regulation, nutrition
Robex weiterhin im Plan für erste Goldproduktion bei Kiniero im vierten Quartal 2025
Producers
Robex weiterhin im Plan für erste Goldproduktion bei Kiniero im vierten Quartal 2025
Robex reste en bonne voie pour une première coulée d’or à Kiniero au quatrième trimestre 2025
Producers
Robex reste en bonne voie pour une première coulée d’or à Kiniero au quatrième trimestre 2025
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
Producers
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Producers
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Producers

Form 8.3 – [ECKOH PLC – 27 08 2024]

August 29, 2024 admin

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…

Producers

Smart for Life to Attend the Newtopia Now 2024 Conference in Colorado

August 29, 2024 admin

MIAMI, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a distinguished leader in the Health & Wellness sector specializing in…

Producers

Form 8.3 – [KEYWORDS STUDIOS PLC – 27 08 2024]

August 29, 2024 admin

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…

Producers

Toll Brothers Apartment Living and The Davis Companies Announce the Grand Opening of Whitlow, a New Luxury Apartment Community in Lewisville, Texas

August 29, 2024 admin

LEWISVILLE, Texas, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Toll Brothers Apartment Living, the rental subsidiary of Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, and joint…

Producers

Groundworks® Extends Seattle Presence with the Acquisition of Rainy Day

August 29, 2024 admin

VIRGINIA BEACH, Va., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Groundworks®, North America’s leading foundation and water management solutions company, today announced its acquisition of Arlington, WA, based Rainy Day Basement…

Producers

NewHydrogen Reports Progress in Developing Cost-Effective Green Hydrogen Technology

August 28, 2024 admin

Collaboration with UC Santa Barbara marks key progress in reducing hydrogen production costs with innovative ThermoLoop™ technology SANTA CLARITA, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCMKTS:NEWH), provided…

Producers

Update: U.S. Insurance Industry Begins to See Surplus Recovery, Boosted by First Half Capital Gains and Signs of U.S. Property and Casualty Firms Inching Towards Stabilization

August 28, 2024 admin

JERSEY CITY, N.J., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, and The American Property Casualty Insurance Association (APCIA), the primary…

Producers

Tactical Resources Provides Additional Information Regarding Its Proposed Business Combination With Plum Acquisition Corp. III

August 28, 2024 admin

VANCOUVER, British Columbia, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Tactical Resources Corp. (TSX.V: RARE | OTC: USREF) (“Tactical Resources” or the “Company”), a mineral exploration and development company, is pleased…

Producers

Sýn hf.: Afkoma Sýnar hf. á fyrri helmingi ársins 2024

August 28, 2024 admin

Árangur í fullu samræmi við útgefna afkomuspá Árshlutareikningur samstæðu Sýnar hf. fyrir fyrstu sex mánuði ársins 2024 var samþykktur á stjórnarfundi þann 28. ágúst 2024. Rekstrarhagnaður (EBIT) Sýnar hf. nam…

Producers

TowneBank Announces Quarterly Cash Dividend

August 28, 2024 admin

SUFFOLK, Va., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Hampton Roads based TowneBank (NASDAQ: TOWN) announced today that its Board of Directors declared its third-quarter shareholder cash dividend of $0.25 per…

Posts pagination

1 … 363 364 365 … 380

Recent Posts

  • Robex weiterhin im Plan für erste Goldproduktion bei Kiniero im vierten Quartal 2025
  • Robex reste en bonne voie pour une première coulée d’or à Kiniero au quatrième trimestre 2025
  • [Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
  • Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
  • Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

Producers Online
Producers Online

No comments to show.

Archives

  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • November 2024
  • October 2024
  • September 2024
  • August 2024

Categories

  • Producers
  • Българо-китайска търговско-промишлена палата

You missed

Producers

Robex weiterhin im Plan für erste Goldproduktion bei Kiniero im vierten Quartal 2025

June 16, 2025 admin
Producers

Robex reste en bonne voie pour une première coulée d’or à Kiniero au quatrième trimestre 2025

June 16, 2025 admin
Producers

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients

June 16, 2025 admin
Producers

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

June 16, 2025 admin

Producers Online

Producers Online

Proudly powered by WordPress | Theme: Newsup by Themeansar.

  • Home
  • Producers online